Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Pharmacogenetics of Antipsychotic Treatment Response in Schizophrenia
FY 2014-15
Summary
Schizophrenia is a highly debilitating and heritable neurodevelopmental disorder that affects 1% of the world's population. Antipsychotic medication is the most effective treatment, yet success rates still hover around a mediocre 60%. Physicians must often start their patient on multiple antipsychotics before finding a drug with reasonable benefit, while precious treatment time is wasted and their patients experience an array of detrimental side effects. The burgeoning field of pharmacogenetics addresses this problem by using a patient's genetic information to predict antipsychotic response and side effects. Recent groundbreaking discoveries in schizophrenia genetics have provided numerous promising leads for discoveries in pharmacogenetics, highlighting, in particular, the involvement of numerous genes in the dopamine system. Thus, my project aims to discover novel associations between these dopamine system-related genes and antipsychotic response. The findings will help expand a surprisingly small body of knowledge guiding clinicians to prescribe the best antipsychotic treatment for their patients on the first try, improving patient outcome and cutting down treatment costs. Moreover, my project will shed light on antipsychotic mechanisms of action, inform future drug design, and provide an abundance of novel targets for further antipsychotic response research.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331591
Name
Huang Eric
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Pharmacogenetics of Antipsychotic Treatment Response in Schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Age Of Onset; Antipsychotic Treatment; Clozapine; Dopamine Receptor Genes; Dopamine System; Pharmacogenetics; Schizophrenia
Abstract
Schizophrenia is a highly debilitating and heritable neurodevelopmental disorder that affects 1% of the world's population. Antipsychotic medication is the most effective treatment, yet success rates still hover around a mediocre 60%. Physicians must often start their patient on multiple antipsychotics before finding a drug with reasonable benefit, while precious treatment time is wasted and their patients experience an array of detrimental side effects. The burgeoning field of pharmacogenetics addresses this problem by using a patient's genetic information to predict antipsychotic response and side effects. Recent groundbreaking discoveries in schizophrenia genetics have provided numerous promising leads for discoveries in pharmacogenetics, highlighting, in particular, the involvement of numerous genes in the dopamine system. Thus, my project aims to discover novel associations between these dopamine system-related genes and antipsychotic response. The findings will help expand a surprisingly small body of knowledge guiding clinicians to prescribe the best antipsychotic treatment for their patients on the first try, improving patient outcome and cutting down treatment costs. Moreover, my project will shed light on antipsychotic mechanisms of action, inform future drug design, and provide an abundance of novel targets for further antipsychotic response research.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Huang, Eric
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~